Thymostimulin in advanced hepatocellular carcinoma: A phase II trial

被引:0
作者
Matthias M Dollinger
Christa M Behrens
Joachim Lesske
Susanne Behl
Curd Behrmann
Wolfgang E Fleig
机构
[1] Martin-Luther-University Halle-Wittenberg,First Department of Medicine
[2] Bad Reichenhall Hospital,Department of Medicine
[3] Martin-Luther-University Halle-Wittenberg,Department of Radiology
[4] University of Leipzig Hospitals and Clinics,undefined
来源
BMC Cancer | / 8卷
关键词
Liver Cirrhosis; Tace; Extrahepatic Metastasis; Barcelona Clinic Liver Cancer; Good Supportive Care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 168 条
  • [1] Bosch FX(2004)Primary liver cancer: Worldwide incidence and trends Gastroenterology 127 S5-S16
  • [2] Ribes J(2002)Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 519-524
  • [3] Díaz M(2003)Hepatocellular carcinoma: Primary and secondary prophylaxis as well as medical therapy Chir Gastroenterol 19 247-252
  • [4] Cléries R(2005)Local/regional and systemic treatments of hepatocellular carcinoma Semin Liver Dis 25 201-211
  • [5] Bruix J(2003)Immunobiology and gene-based immunotherapy of hepatocellular carcinoma Z Gastroenterol 41 1101-1110
  • [6] Llovet JM(1996)Thymostimulin treatment of hepatocellular carcinoma on liver cirrhosis Int J Oncol 8 827-832
  • [7] Fleig WE(2005)Roles of thymosins in cancers and other organ systems World J Surg 29 264-270
  • [8] Lesske J(2001)Thymic hormones in cancer diagnostics and treatment Exp Opin Biol Ther 1 93-107
  • [9] Beaugrand M(1994)Thymostimulin: a review of its pharmacology and prospective role in immunotherapy Clin Immunother 1 378-398
  • [10] N'kontchou G(1997)Activation of human Kupffer cells by thymostimulin (TP-1) to produce cytotoxicity against human hepatocellular cancer Ann Surg Oncol 4 149-155